Glenmark gets USFDA nod for acne treatment drug

Glenmark Pharmaceuticals has received final approval by the United States Food and Drug Administration (USFDA) for Clindamycin Phosphate Gel USP, 1 per cent, the company said in a regulatory filing.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3aQAbwY
via IFTTT